These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 23035031)

  • 21. Cytokines: abnormalities in major depression and implications for pharmacological treatment.
    O'Brien SM; Scott LV; Dinan TG
    Hum Psychopharmacol; 2004 Aug; 19(6):397-403. PubMed ID: 15303243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies.
    Epstein J; Sanderson IR; Macdonald TT
    Br J Nutr; 2010 Jun; 103(11):1545-57. PubMed ID: 20100380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The protective role of curcumin in cardiovascular diseases.
    Wongcharoen W; Phrommintikul A
    Int J Cardiol; 2009 Apr; 133(2):145-51. PubMed ID: 19233493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges associated with curcumin therapy in Alzheimer disease.
    Belkacemi A; Doggui S; Dao L; Ramassamy C
    Expert Rev Mol Med; 2011 Nov; 13():e34. PubMed ID: 22051121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric.
    Aggarwal BB; Yuan W; Li S; Gupta SC
    Mol Nutr Food Res; 2013 Sep; 57(9):1529-42. PubMed ID: 23847105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do glutamatergic agents represent a new class of antidepressant drugs? Part 1.
    Sanacora G
    J Clin Psychiatry; 2009 Oct; 70(10):1473-5. PubMed ID: 19906350
    [No Abstract]   [Full Text] [Related]  

  • 27. Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats.
    Li YC; Wang FM; Pan Y; Qiang LQ; Cheng G; Zhang WY; Kong LD
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):435-49. PubMed ID: 19302828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the Endocannabinoid/CB1 Receptor System For Treating Major Depression Through Antidepressant Activities of Curcumin and Dexanabinol-Loaded Solid Lipid Nanoparticles.
    He X; Yang L; Wang M; Zhuang X; Huang R; Zhu R; Wang S
    Cell Physiol Biochem; 2017; 42(6):2281-2294. PubMed ID: 28848078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of neurotransmitters to the symptoms of major depressive disorder.
    Nutt DJ
    J Clin Psychiatry; 2008; 69 Suppl E1():4-7. PubMed ID: 18494537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nicotine as an antidepressant and regulator of sleep in subjects with depression].
    Vieyra-Reyes P; Venebra-Muñoz A; Rivas-Santiago B; García-García F
    Rev Neurol; 2009 Dec 16-31; 49(12):661-7. PubMed ID: 20013719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.
    Aggarwal BB; Sung B
    Trends Pharmacol Sci; 2009 Feb; 30(2):85-94. PubMed ID: 19110321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical examination of studies on curcumin for depression.
    Andrade C
    J Clin Psychiatry; 2014 Oct; 75(10):e1110-2. PubMed ID: 25373119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease.
    Zbarsky V; Datla KP; Parkar S; Rai DK; Aruoma OI; Dexter DT
    Free Radic Res; 2005 Oct; 39(10):1119-25. PubMed ID: 16298737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of steroid activity in chronic inflammation: a novel anti-inflammatory role for curcumin.
    Biswas S; Rahman I
    Mol Nutr Food Res; 2008 Sep; 52(9):987-94. PubMed ID: 18327875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentials of curcumin as an antidepressant.
    Kulkarni S; Dhir A; Akula KK
    ScientificWorldJournal; 2009 Nov; 9():1233-41. PubMed ID: 19882093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression.
    Maes M
    Neuro Endocrinol Lett; 2008 Jun; 29(3):287-91. PubMed ID: 18580840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits.
    Wang Q; Sun AY; Simonyi A; Jensen MD; Shelat PB; Rottinghaus GE; MacDonald RS; Miller DK; Lubahn DE; Weisman GA; Sun GY
    J Neurosci Res; 2005 Oct; 82(1):138-48. PubMed ID: 16075466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin and endometriosis: Review on potential roles and molecular mechanisms.
    Arablou T; Kolahdouz-Mohammadi R
    Biomed Pharmacother; 2018 Jan; 97():91-97. PubMed ID: 29080464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin for depression: a meta-analysis.
    Fusar-Poli L; Vozza L; Gabbiadini A; Vanella A; Concas I; Tinacci S; Petralia A; Signorelli MS; Aguglia E
    Crit Rev Food Sci Nutr; 2020; 60(15):2643-2653. PubMed ID: 31423805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-HT7 receptor antagonists as a new class of antidepressants.
    Mnie-Filali O; Lambás-Señas L; Zimmer L; Haddjeri N
    Drug News Perspect; 2007 Dec; 20(10):613-8. PubMed ID: 18301795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.